STOCK TITAN

Syra Health awards COO and CFO 60,687 stock options

Performance-unit vesting is subject to achievement of certain company financial metrics, while options and restricted stock units vest on dates through 2030.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4/A

Rhea-AI Filing Summary

Syra Health Corp COO and CFO Priya Prasad received compensation-related awards on August 31, 2026: 86,696 Performance Stock Units, 60,687 stock options, and 26,009 Restricted Stock Units. Those amounts are her reported post-transaction positions in each award. The options have an exercise price of $0.92 per share.

Twenty percent of the Performance Stock Units vest each year after the grant, subject to achievement of certain company financial metrics. Twenty percent of the options and restricted stock units vest on each December 31 from 2026 through 2030.

Insider Prasad Priya
Role COO and CFO
Type Security Shares Price Value
Grant/Award Performance Stock Units F1 86,696 $0.00 $0.00
Grant/Award Stock Options F2 60,687 $0.00 $0.00
Grant/Award Restricted Stock Units F3 26,009 $0.00 $0.00
Holdings After Transaction: Performance Stock Units — 86,696 contracts (Direct); Stock Options — 60,687 contracts (Direct); Restricted Stock Units — 26,009 contracts (Direct)
Footnotes (3)
  1. F1. 20% of the Performance Stock Units vest each year after date of grant subject to the achievement of certain company financial metrics.
  2. F2. 20% of the options vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.
  3. F3. 20% of the restricted stock units vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.
Performance Stock Units 86,696 units Award dated August 31, 2026; reported post-transaction position
Stock Options 60,687 options Award dated August 31, 2026; reported post-transaction position
Option exercise price $0.92 per share Options awarded August 31, 2026
Restricted Stock Units 26,009 units Award dated August 31, 2026; reported post-transaction position
Performance Stock Units financial
"20% of the Performance Stock Units vest each year"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
Restricted Stock Units financial
"20% of the restricted stock units vest on each"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
exercise price financial
"options have an exercise price of $0.92"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What awards did SYRA's COO and CFO receive?

COO and CFO Priya Prasad received 86,696 Performance Stock Units, 60,687 stock options, and 26,009 Restricted Stock Units on August 31, 2026. The options have an exercise price of $0.92 per share.

How do the SYRA awards vest?

Twenty percent of the Performance Stock Units vest each year after the grant, subject to achievement of certain company financial metrics. Twenty percent of the options and restricted stock units vest on each December 31, 2026, 2027, 2028, 2029 and 2030.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Prasad Priya

(Last)(First)(Middle)
C/O SYRA HEALTH CORP.
1119 KEYSTONE WAY N., #201

(Street)
CARMEL INDIANA 46032

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Syra Health Corp [ SYRA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
COO and CFO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
09/02/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Performance Stock Units$0.008/31/2026A86,696 (1)08/31/2036Class A Common Stock86,696$086,696D
Stock Options$0.9208/31/2026A60,687 (2)08/31/2036Class A Common Stock60,687$060,687D
Restricted Stock Units$0.008/31/2026A26,009 (3) (3)Class A Common Stock26,009$026,009D
Explanation of Responses:
1. 20% of the Performance Stock Units vest each year after date of grant subject to the achievement of certain company financial metrics.
2. 20% of the options vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.
3. 20% of the restricted stock units vest on each of December 31, 2026, 2027, 2028, 2029 and 2030.
/s/ Priya Prasad09/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading